Literature DB >> 22024264

Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage.

Daniel T Rein1, Torsten Schmidt, Alexandra P Hess, Anne Volkmer, Thomas Schöndorf, Martina Breidenbach.   

Abstract

STUDY
OBJECTIVE: The aim of this study was to estimate the rate of intrauterine adhesions and subsequent pregnancy outcome in patients with residual trophoblastic tissue treated with hysteroscopic resection versus ultrasound-guided dilation and evacuation (D&E).
DESIGN: Cohort study from 2 centers (Canadian Task Force classification II-2).
SETTING: Two surgical teams at the University of Duesseldorf Medical Center and the PAN Clinic in Cologne, Germany. PATIENTS: Women with residual trophoblastic tissue after first- or second-trimester miscarriage or term delivery. INTERVENTION: Two techniques were used for the removal of residual trophoblastic tissue: ultrasound-guided evacuation with a curette (D&E) and hysteroscopic resection of trophoblastic tissue (HR).
MEASUREMENTS AND MAIN RESULTS: We evaluated 95 patients who underwent secondary intervention for residual trophoblastic disease. A total of 42 patients underwent dilation of the cervix and ultrasound-guided curettage. In a second series of 53 patients, a resectoscope fitted with a 4-mm cutting loop was used for the removal of residual trophoblastic tissue used without application of current. Three months after the intervention, second-look office hysteroscopy was performed. Differences between both treatment groups were statistically significant. After HR, mild intrauterine adhesions were found in 2 patients (4.2%). After D&E, 12 patients (30.8%) presented with intrauterine adhesions (mild intrauterine adhesions: n = 7 [17.9%]; single dense adhesions: n = 3 [7.7%]; and extensive endometrial fibrosis n = 1 [2.6%]). Eighty-two patients wanted to become pregnant. Conception rate of all patients examined was 68.8% (HR) and 59.9% (D&E) (p < .05). In patients younger than 35 years of age who underwent HR, the pregnancy rate was significantly (p < .05) increased compared with patients who underwent D&E (78.1% vs 66.6%). In addition, patients from the HR group demonstrated a significantly (p < .05) shorter time to conception (11.5 month vs 14.5 month).
CONCLUSION: The results of this study indicate that selective HR of residual trophoblastic tissue significantly reduces the incidence of intrauterine adhesions and increases pregnancy rates.
Copyright © 2011 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22024264     DOI: 10.1016/j.jmig.2011.08.003

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  18 in total

1.  Definition and Multiple Factors of Recurrent Spontaneous Abortion.

Authors:  Xiaolin La; Wenjuan Wang; Meng Zhang; Li Liang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Exosomes derived from human umbilical cord mesenchymal stem cells repair injured endometrial epithelial cells.

Authors:  Linlin Liang; Lu Wang; Shihao Zhou; Jingyu Li; Li Meng; Helong Zhang; Chenchen Cui; Cuilian Zhang
Journal:  J Assist Reprod Genet       Date:  2020-01-15       Impact factor: 3.412

3.  Hysteroscopic resection for management of early pregnancy loss: a case report and literature review.

Authors:  Stacy Young; Charles E Miller
Journal:  F S Rep       Date:  2022-03-10

4.  High-intensity focused ultrasound combined with hysteroscopic resection to treat retained placenta accreta.

Authors:  Jae-Seong Lee; Gi-Youn Hong; Byung-Joon Park; Hyejin Hwang; Rayon Kim; Tae-Eung Kim
Journal:  Obstet Gynecol Sci       Date:  2016-09-13

5.  AAGL practice report: practice guidelines on intrauterine adhesions developed in collaboration with the European Society of Gynaecological Endoscopy (ESGE).

Authors: 
Journal:  Gynecol Surg       Date:  2017-05-01

6.  Level of depression, anxiety and stress in patients with intrauterine adhesions in Hunan Province, China: A cross-sectional study.

Authors:  Ting Wang; Yanhui Zhou; Jingxia Fu; Mingzhu Chen; Yang Luo
Journal:  PLoS One       Date:  2020-03-11       Impact factor: 3.240

7.  Operative hysteroscopy versus vacuum aspiration for incomplete spontaneous abortion (HY-PER): study protocol for a randomized controlled trial.

Authors:  Cyrille Huchon; Martin Koskas; Aubert Agostini; Cherif Akladios; Souhail Alouini; Estelle Bauville; Nicolas Bourdel; Hervé Fernandez; Xavier Fritel; Olivier Graesslin; Guillaume Legendre; Jean-Philippe Lucot; Isabelle Matheron; Pierre Panel; Cyril Raiffort; Arnaud Fauconnier
Journal:  Trials       Date:  2015-08-19       Impact factor: 2.279

Review 8.  The management of Asherman syndrome: a review of literature.

Authors:  Alessandro Conforti; Carlo Alviggi; Antonio Mollo; Giuseppe De Placido; Adam Magos
Journal:  Reprod Biol Endocrinol       Date:  2013-12-27       Impact factor: 5.211

9.  Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial.

Authors:  Yun Cao; Haixiang Sun; Hui Zhu; Xianghong Zhu; Xiaoqiu Tang; Guijun Yan; Jingmei Wang; Donghui Bai; Juan Wang; Liu Wang; Qi Zhou; Huiyan Wang; Chengyan Dai; Lijun Ding; Biyun Xu; Yan Zhou; Jie Hao; Jianwu Dai; Yali Hu
Journal:  Stem Cell Res Ther       Date:  2018-07-11       Impact factor: 6.832

10.  Intrauterine infusion of platelet-rich plasma is a treatment method for patients with intrauterine adhesions after hysteroscopy.

Authors:  Jintao Peng; Manzhao Li; Haitao Zeng; Zhi Zeng; Jiana Huang; Xiaoyan Liang
Journal:  Int J Gynaecol Obstet       Date:  2020-09-21       Impact factor: 3.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.